Pharmaceutical and services company Clinigen Group has signed a commercial agreement with Bristol-Myers Squibb in South Africa, it announced on Thursday.
Britvic: Berenberg upgrades to buy with a target price of 900p.
Forterra: Citigroup downgrades to neutral with a target price of 350p.
Rightmove: JP Morgan upgrades to neutral with a target price of 4,168p.
Clinigen's acquisition of AIM peer Quantum Pharma, a manufacturer and supplier of unlicensed medicines and special obtain products, was approved on Tuesday.
AIM-listed pharmaceutical and services company Clinigen has acquired International Medical Management Corporation (IMMC), Japan's largest supplier of unlicensed medicines, for an undisclosed sum.
Clinigen Group and Quantum Pharma announced on Wednesday that they have agreed terms of a recommended acquisition by Clinigen of the entire issued and to-be-issued share capital of Quantum for £150.3m, to be effected by means of a scheme of arrangement.
UK pharmaceutical developer Quantum Pharma announced it had received an indicative proposal of a possible offer for the company from Clinigen Group.
Pharmaceutical and services company Clinigen Group expects gross profit for its full year to be up 22%, it said on Tuesday, driven by a combination of organic growth across all of its operations, as well as a whole year's contribution from Link Healthcare and currency benefits.
Global pharmaceutical and services company Clinigen Group confirmed it had obtained approval from the US Food and Drug Administration for its 'Totect' dexrazoxane hydrochloride product on Monday, alongside Cumberland Pharmaceuticals.
Clinigen Group's Idis Managed Access division and Onxeo agreed to launch a managed access programme for belinostat - branded Beleodaq - in Europe on Tuesday.
AIM-listed Pharmaceuticals Clinigen and Diurnal are to launch a managed access programme in Europe for their drugs Infacort, which treats children with adrenal insufficiency, and Chronocort, which treat patients with congenital adrenal hyperplasia.
Global pharmaceutical and services company Clinigen Group provided a trading update for the six months to 31 December on Wednesday, with gross profit up 34%.
Clinigen Group announced on Tuesday that its Idis Managed Access division has partnered with TESARO to launch a managed access program for the investigational PARP 1/2 inhibitor, niraparib.
Clinigen Group, an AIM listed global pharmaceutical and services company, and Cumberland Pharmaceuticals, a US specialty pharmaceutical company have entered into their second exclusive agreement to commercialise the oncology support drug Totect in the US.
AIM-listed pharmaceutical Clinigen is to distribute BioQ Pharma's post-surgery pain management drug, Ropivacaine Readyfusor.
Pharmaceutical companies Clinigen and Eisai launched an advanced breast cancer treatment for women in South Africa called Halaven (eribulin).
Clinigen Group director John Bacon has sold £1.4m of the pharmaceuticals and clinical trial services group.
Global pharmaceutical and services company Clinigen Group said its trading for the current financial year is in-line with directors' expectations.
Pharmaceuticals giants want the government to plug a £1bn-a-year funding gap that will be created when Britain leaves the EU, as part of a list of demands being drawn up by big business after last week's deal with Nissan. After the Japanese car maker said it would make two new models at its Sunderland plant - safeguarding nearly 7,000 jobs - after receiving written assurances about post-Brexit trading arrangements from business secretary Greg Clark, other big employers from key sectors are now using Nissan's perceived sweetheart deal as leverage to ask for their own favours. - Sunday Times